Анализ акций NEWBRY.ST
NE
Нет оценки
Количественный анализ Eyestock не покрывает акции Newbury Pharmaceuticals AB.
Капитализация млрд. $
0.02
Дивидендная доходность
—
Оборот
19.52 млрд
Сайт компании
https://www.newburypharma.comNewbury Pharmaceuticals AB is a hybrid pharmaceutical company, which engages in specialty prescription drugs inn the Scandinavian markets. The company is headquartered in Lund, Skane. The company went IPO on 2022-02-04. The Company’s existing portfolio is focused on the Scandinavian market and consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology.
Смотреть Секцию: Рейтинг